CARBONI, EZIO
 Distribuzione geografica
Continente #
EU - Europa 158.685
NA - Nord America 8.314
AS - Asia 3.031
SA - Sud America 556
AF - Africa 62
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 9
Totale 170.686
Nazione #
IT - Italia 156.235
US - Stati Uniti d'America 8.206
CN - Cina 1.333
SG - Singapore 1.171
UA - Ucraina 729
DE - Germania 529
BR - Brasile 474
SE - Svezia 439
GB - Regno Unito 226
FI - Finlandia 208
VN - Vietnam 117
KR - Corea 97
FR - Francia 93
RU - Federazione Russa 73
CA - Canada 71
HK - Hong Kong 54
IN - India 40
AR - Argentina 37
JP - Giappone 35
NL - Olanda 32
BD - Bangladesh 29
MX - Messico 26
AU - Australia 23
ES - Italia 19
IE - Irlanda 19
PL - Polonia 19
TR - Turchia 19
IR - Iran 17
CL - Cile 16
PK - Pakistan 13
TH - Thailandia 13
ZA - Sudafrica 13
AT - Austria 12
BE - Belgio 12
EG - Egitto 11
IL - Israele 11
IQ - Iraq 11
UZ - Uzbekistan 10
EC - Ecuador 9
EU - Europa 9
GH - Ghana 9
ID - Indonesia 9
MA - Marocco 8
OM - Oman 8
CY - Cipro 7
CZ - Repubblica Ceca 7
KE - Kenya 7
NZ - Nuova Zelanda 6
TW - Taiwan 6
VE - Venezuela 6
CO - Colombia 5
GR - Grecia 5
BO - Bolivia 4
KZ - Kazakistan 4
LT - Lituania 4
SA - Arabia Saudita 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
DZ - Algeria 3
JM - Giamaica 3
MU - Mauritius 3
MY - Malesia 3
NP - Nepal 3
RO - Romania 3
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
HU - Ungheria 2
JO - Giordania 2
KW - Kuwait 2
LU - Lussemburgo 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
ZW - Zimbabwe 1
Totale 170.686
Città #
Cagliari 152.630
Uta 3.203
Fairfield 878
Woodbridge 871
Ashburn 582
Chandler 565
Singapore 516
Houston 484
Boardman 405
Ann Arbor 404
Jacksonville 403
Wilmington 388
Seattle 379
Dallas 330
Nyköping 280
Cambridge 277
Dearborn 252
Beijing 215
Hefei 125
Nanjing 119
Los Angeles 117
Santa Clara 102
Boston 99
Seoul 86
Shanghai 86
Helsinki 85
Guangzhou 73
Buffalo 63
New York 58
The Dalles 53
San Diego 46
Shenyang 45
Milan 41
Redwood City 40
Ho Chi Minh City 39
Hebei 38
Toronto 37
São Paulo 34
Nanchang 32
Jiaxing 29
Mountain View 28
Hong Kong 26
Tianjin 26
Hanoi 25
Jinan 24
Changsha 23
Munich 22
Frankfurt am Main 21
Norwalk 21
Atlanta 20
Zhengzhou 19
London 18
Tokyo 18
Verona 18
Redondo Beach 17
San Francisco 17
Assèmini 16
Council Bluffs 16
Brooklyn 15
Dublin 15
Orange 14
Turku 14
Washington 14
Auburn Hills 13
Chicago 13
San Mateo 13
Amsterdam 12
Augusta 12
Brussels 12
Belo Horizonte 11
Dhaka 11
Ningbo 11
Rio de Janeiro 11
Warsaw 11
Kunming 10
Montreal 10
Tashkent 10
Wuhan 10
Accra 9
Denver 9
Rome 9
Columbus 8
Da Nang 8
Detroit 8
Indiana 8
Pune 8
Saint Petersburg 8
Sassari 8
Bradford 7
Bristol 7
Douglasville 7
Falls Church 7
Fuzhou 7
Guarulhos 7
Hangzhou 7
Nicosia 7
Pittsburgh 7
Quartu Sant'Elena 7
Sydney 7
Taizhou 7
Totale 165.293
Nome #
Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area 5.386
Differential sensitivity of ethanol-elicited ERK phosphorylation in nucleus accumbens of Sardinian alcohol-preferring and -non preferring rats 4.126
null 4.110
Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum 3.612
The MPTP/probenecid model of progressive Parkinson's disease 3.482
Increase of dopamine and norepinephrine release in the bed nucleus of stria terminalis: a common feature of antidepressants? 3.469
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 3.404
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. 3.226
PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests nigrostriatal degeneration in a progressive Parkinson’s disease model. 3.131
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 2.979
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? 2.828
PRENATAL RESTRAINT STRESS: AN IN VIVO MICRODIALYSIS STUDY ON CATECHOLAMINE RELEASE IN THE RAT PREFRONTAL CORTEX 2.794
52) Carboni E., Ibba M., Schirru C., Sadile A. (2009). BEHAVIORAL AND NEUROCHEMICAL CHANGES INDUCED BY METHYLPHENIDATE OR ATOMOXETINE SUB-CHRONIC TREATMENT IN ADOLESCENT SPONTANEOUS HYPERTENSIVE RATS (SHR) ARE GENDER SPECIFIC 2.698
Long term effects of adolescent chronic mild stress on brain catecholamine transmission in rat brain: a microdialysis study 2.622
null 2.592
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? 2.552
The alpha 7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain 2.518
Prepuberal Stimulation of 5-HT7-R by LP-211 in a Rat Model of Hyper-Activity and Attention-Deficit: Permanent Effects on Attention, Brain Amino Acids and Synaptic Markers in the Fronto-Striatal Interface 2.516
Different classes of antidepressants increase dopamine and norepinephrine release in the bed nucleus of stria terminalis: an “in vivo” microdialysis study 2.515
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.454
The α7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain 2.438
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease 2.393
Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats 2.241
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease 2.204
Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine 2.199
null 2.160
Different classes of antidepressants share the ability to increase dopamine and norepinephrine release in the bed nucleus of stria terminalis: A possible role in antidepressant therapy? 2.142
Chronic methylphenidate or atomoxetine treatment alters BDNF expression in the brain of spontaneously hypertensive rats 2.070
PPAR-GAMMA RECEPTOR AGONIST PREVENTS NEURODEGENERATION AND BEHAVIOURAL DEFICITS IN A CHRONIC MPTP MOUSE MODEL OF PARKINSON’S DISEASE. 2.060
Drug induced release of dopamine and noradrenaline in the forebrain of the prenatally stressed rats 1.998
The interrelationship between dopamine and noradrenaline in the prefrontal cortex: From physiology to therapy 1.971
(D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens 1.964
PROGRESSIVE DECLINE OF BEHAVIORAL AND BIOCHEMICAL PARAMETERS IN THE CHRONIC MPTP/PROBENECID MOUSE MODEL OF PARKINSON’S DISEASE. 1.923
PEROXIZOME-PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARG) AGONIST ROSIGLITAZONE COUNTERACTS BEHAVIORAL AND BIOCHEMICAL DEFICITS IN A CHRONIC 1-METHYL-4-PHENIL-1,2,3,4 TETRAHYDROPYRIDINE (MPTP) MOUSE MODEL OF PARKINSON’S DISEASE 1.844
METHYLPHENIDATE AND ATOMOXETINE AFFECT BDNF EXPRESSION IN THE BRAIN OF SPONTANEOUS HYPERTENSIVE RATS. 1.831
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. 1.768
Enhanced limbic/impaired cortical-loop connection onto the hippocampus of NHE rats: Application of resting-state functional connectivity in a preclinical ADHD model 1.744
Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: virus-based models versus inoculation of exogenous preformed toxic species 1.744
Effects of sub-chronic methylphenidate and atomoxetine on noradrenaline and dopamine transmission in the prefrontal cortex of adolescent SH rats, an animal model of ADHD 1.701
Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats 1.636
Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice 1.619
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 1.553
Prenatal restraint stress differentially modifies basal and stimulated dopamine and noradrenaline release in the nucleus accumbens shell: an 'in vivo' microdialysis study in adolescent and young adult rats. 1.505
CAFFEINE AND ACCUMBENS SHELL DOPAMINE 1.490
Gender specific reduction of hypermotility by sub-chronic methylphenidate or atomoxetine in SH rats, an animal model of ADHD 1.419
PREPUBERAL SUBCHRONIC METHYLPHENIDATE AND ATOMOXETINE INDUCE DIFFERENTIAL LONG TERM EFFECTS ON ADULT BEHAVIOR AND FOREBRAIN DOPAMINE, NOREPINEPHRINE AND SEROTONIN IN NAPLES HIGH EXCITABILITY RATS 1.362
Can pioglitazone be potentially useful therapeutically in treating patients with Covid-19? 1.343
DIFFERENT EFFECTS OF METHYLPHENIDATE AND ATOMOXETINE ON BDNF EXPRESSION IN THE BRAIN OF SPONTANEOULSY HYPERTENSIVE RATS 1.322
Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats. 1.312
Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs 1.266
Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex 1.224
CHRONIC TREATMENT WITH METHYLPHENIDATE OR ATOMOXETINE DETERMINES CHANGES OF NORADRENARGIC AND DOPAMINERGIC TRANSMISSION IN THE PREFRONTAL CORTEX OF ADOLESCENT SPONTANEOUS HYPERTENSIVE RATS (SHR): A MICRODIALYSIS STUDY. 1.187
DOPAMINERGIC NEUROTRANSMISSION IN A RAT MODEL OF PRENATAL STRESS 1.131
Function of dopamine in the extrapyramidal and limbic systems 1.091
42) Carboni E, Silvagni A, Barros VG, Di Chiara G. (2006). BASAL AND AMPHETAMINE STIMULATED DOPAMINE AND NORADRENALINE TRANSMISSION IN RAT BRAIN ARE DIFFERENTIALLY AFFECTED BY PRENATAL STRESS: AN IN VIVO MICRODIALYSIS STUDY. 1.081
INCREASE OF EXTRACELLULAR DOPAMINE IN THE PREFRONTAL CORTEX - A TRAIT OF DRUGS WITH ANTIDEPRESSANT POTENTIAL 1.076
Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence. 1.011
Similarities and differences between nicotine and food reward relevance for a theory of reward. 996
Antidepressants, dose dependently, increase dopamine and norepinephrine extracellular concentration in rat bed nucleus of stria terminalis: a microdialysis study 965
BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression 957
A microdyalisis study of dopamine transmission in the nucleus accumbens shell of SHR rats: a model of attention deficit hyperactivity disorder (ADHD) 951
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 946
A MICRODIALYSIS STUDY OF DOPAMINE TRANSMISSION IN THE NUCLEUS ACCUMBENS SHELL OF SHR RATS: A MODEL OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) 901
Stimulation of Dopamine Release in the Bed Nucleus of Stria Terminalis. A Trait of Atypical Antipsychotics? 875
Naples high excitability and spontaneously hypertensive model different variants of attention-deficit hyperactivity disorder 863
Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats 821
Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics 793
A challenge dose of amphetamine can be used as a tollo for assessing changes in dopamine and noradrenaline transmission induced by prenatal stress in rats 791
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 761
Detection of 3H-cimetidine specific binding in rat anterior pituitary 751
Effect of amphetamine, cocaine and experimental Investigation on dopamine trasmission can provide clues on the mechanism of action of amphetamine and methylphenidate in ADHD 751
Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study 736
Effect of Dopamine and Norepinephrine Carrier Blockade on Extracellular Dopamine Release in Rat Brain 734
Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD. 732
6-Hydroxydopamine lesions reduce specific [3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors 721
Dopamine reuptake by norepinephrine neurons: exception or rule? 704
Role of prefrontal cortex dopamine and noradrenaline circuitry in addiction 692
5HT3 antagonists specifically block morphine and nicotine reward 679
Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and fos immunohistochemistry 676
Dopamine and drug addiction: the nucleus accumbens shell connection 646
EFFECT OF PRENATAL STRESS ON BASAL AND STIMULATED DOPAMINE AND NORADRENALINE TRANSMISSION IN RAT BRAIN: IN VIVO MICRODIALYSIS STUDY. 640
null 638
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success? 638
null 637
null 622
CONDITIONED PLACE PREFERENCE: A SIMPLE METHOD FOR INVESTIGATING REINFORCING PROPERTIES IN LABORATORY ANIMALS 620
Dihydropyridines change the uptake of calcium induced by depolarization into primary cultures of cerebellar granule cells. 619
Ethanol: lack of stimulation of chloride influì in rat brain synaptoneurosomes 617
null 617
Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS. 614
COMBINED MICRODIALYSIS AND FOS IMMUNOHISTOCHEMISTRY FOR THE ESTIMATION OF DOPAMINE NEUROTRANSMISSION IN THE RAT CAUDATE-PUTAMEN 606
Serotonin release and metabolism in rat cortex as studied by transcerebral dialysis. 602
null 586
null 583
null 580
SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia. 574
null 568
null 568
Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line 563
Dihydropyridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebellar granule cells. 558
Totale 155.529
Categoria #
all - tutte 214.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 214.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113.555 0 0 0 0 0 3.611 3.360 1.955 747 1.343 1.467 1.072
2021/20227.585 777 486 746 362 481 509 647 489 475 877 717 1.019
2022/202313.596 1.072 1.834 1.208 1.046 1.177 1.179 758 1.094 1.032 1.178 1.395 623
2023/202413.893 606 612 734 830 1.398 2.199 2.279 1.067 631 1.059 1.092 1.386
2024/202530.084 8.438 9.025 4.070 2.666 1.594 1.630 1.320 191 282 272 292 304
2025/20263.526 362 308 918 534 515 889 0 0 0 0 0 0
Totale 170.883